Automated Cell Processing Systems Market Report 2026-2035: Industry Poised for 16% CAGR Growth Amid Biotechnology Breakthroughs
Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Automated Cell Processing System Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Cell Therapy Processing Step, Scale of Operation, End User and Key Geographical Regions" has been added to ResearchAndMarkets.com's offering.
The global automated cell processing system market, currently valued at USD 220 million, is anticipated to expand at a CAGR of 16% during the forecast period. This press release delves into the market's dynamics, highlighting key segmentation parameters and growth trends.
Market Segmentation:
Market Growth and Trends
Advances in biotechnology have increased cell therapy candidates, with over 2,000 currently being assessed for various diseases. Recognized for their potential in treating cancer, rare, and chronic diseases, cellular therapies are attracting substantial industry interest. Traditional cell therapy manufacturing is labor-intensive and costly, leading to increased demand for efficient solutions. Modern automated and closed systems are expected to significantly reduce production costs.
One prominent example is the GMP-In-A-Box, which enhances throughput, minimizes idle times, and reduces manual labor. Consequently, the cell processing systems market is set to realize lucrative growth.
Key Insights:
Prominent Market Players: AstraZeneca, Baxter, Bayer, Cytiva, Cellular Therapeutics, Lonza, Merck, Pall, Terumo BCT, ThermoGenesis.
Research Coverage and Insights:
Key Questions Answered:
Reasons to Buy:
For more information about this report visit https://www.researchandmarkets.com/r/3maqez
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.